Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Antiviral Res. 2021 May 30;193:105084. doi: 10.1016/j.antiviral.2021.105084

Table 4.

Antiviral profiles of selected hits against NiV-B and HeV infection in Vero 76 cell line

NiV-B HeV
Compound ID IC50 (95% CI) (μM) CC50 (μM) Selectivity index (SI) IC50 (95% CI) (μM) CC50 (μM) Selectivity index (SI)
C1 1.83 (0.96 to 3.50) > 100 > 55 9.87 (6.06 to 16.1) > 100 > 10
F1 4.15 (1.89 to 9.07) > 100 > 24 19.6 (3.48 to 110) > 100 > 5

Note: All IC50 values are estimated by nonlinear fit model from one experiment with duplicates and shown as estimated values with 95% confidence interval (95% CI).